EGFR and non-small cell lung carcinoma: A common oncogenic EFGR mutation is the deletions of exon 19, which appear to promote EGFR tyrosine kinase activity [4,5]; and such deletion mutants account for 45%, or more, of NSCLC cases in Asia [1,3].